Drugs / Ningmitai Capsule
Ningmitai Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05890235 | Nov 2018 → Jul 2022 | chronic prostatitis | Xintian Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ningmitai Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05890235 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Ningmitai Capsule (Ningmitai®) is Traditional Chinese Medicine which has already used in treatment of urinary system disease (eg. CPPS, BPH) in China for more than twenty years.” NCT05890235 ↗ |
| Route | Oral | “Oral Ningmitai capsule, 0.38 g/capsule, tid, 4 capsules each time, after meals, for 8 weeks.” NCT05890235 ↗ |